Saurabh Srivastava

About Saurabh Srivastava

Deep understanding of different work cultures; 15+ years of professional training and work experiences across multiple locations in India and USA, and multiple disciplines (small molecules, peptide/protein biochemistry, Inflammation, Neurodegeneration, Sialic acid biology, Cancer Biomarker Discovery, and Glycan Recognition approaches), with notable accomplishments.• Strong scientific acumen: interested in various sectors of life sciences, diagnostic and biopharma with a strong sense of where my expertise overlaps with the next frontiers and opportunities; specially the glycan-based biomarker and therapeutics. • Received a Ph.D. from Central Drug Research Institute in affiliation with Jawaharlal Nehru University, India on a full academic scholarship. Received the Best PhD Thesis award in Biological Sciences. Qualified for multiple National Academic Scholarships in India.• Identified and characterized the role of sialic acids in prion infections and neuroinflammation at the University of Maryland Baltimore. • Developed & characterized a panel of sialic acid binding probes at University of California San Diego.• Standardized the next gen sequencing approaches to support cancer neoantigen discovery projects at Cleveland Clinic.• Outlined Projects and performed Proof of Concept experiments aligned with Glycoproteomic Biomarker Discovery program at InterVenn Biosciences.• Inventor on glycoproteomic method patent granted to InterVenn Biosciences.• Published 25+ peer reviewed research articles in top-tier scientific journals including PNAS (first author), JBC (first author), Glycobiology (first author), Biochemical Journal (first author), Scientific Reports (first author), etc.• Presented over a dozen oral and poster presentations in national and international conferences. • Reviewed more >100 articles for the BMJ, MDPI, PLOS, and Taylor & Francis publications.• Reviewer for the GlycoMIP- a NSF funded glycobiology material innovation platform from collective efforts of Virginia Tech and University of Georgia.• An attitude for persistence learning; acquired certificates on Project Management (UC San Diego, Google & UC Irvine), Cancer Biology (Johns Hopkins University), Product Management (University of Maryland), Data Analysis (Google), Data Visualization (UC Davis), Statistical Analysis (Imperial College, London), Business Intelligence (Google), AI for health (WHO) and Precision Medicine (University of Geneva).• Independent contributor on Medium platform for writers: Editor of ‘The Human Phenomenon’ and Writer for ‘Illumination’.

Experience

1. Method Development Scientist

   Alexion Pharmaceuticals, Inc.

   Aug 2024 — Present · New Haven, CT, US

Education

• University of Lucknow

  M.Sc.

  2005 — 2007

• University of Maryland

  Postdoctoral Training

  2013 — 2017

• Jawaharlal Nehru University

  Ph.D.

  2008 — 2013

• UC San Diego School of Medicine

  Postdoctoral Training

  2017 — 2019